Answer
The Genus Pharmaceuticals product Pazopanib 400 mg film-coated tablets is not recommended for patients with severe hepatic impairment, defined as total bilirubin greater than three times the upper limit of normal, regardless of the alanine aminotransferase (ALT) value.
Sources for this answer
- Pazopanib 400mg film-coated tabletsGenus Pharmaceuticals · emc · SmPC §4.2 Posology and method of administration · Version 1Document updated
Sources checked